Inhaled Insulin Licensed in the US

The US Food and Drug Administration (FDA) has approved a rapid acting inhaled insulin for use at mealtimes by adults with diabetes mellitus. The product, which will be marketed as Afrezza (insulin human) Inhalation Powder, must be used in combination with long acting insulin in people with type 1 diabetes, the FDA warned. Fitness professionals… Read More

Advertisements
Advertisements

News: The UK, Children & Type 1 Diabetes

The UK ranks fifth of 88 countries in the incidence of type 1 diabetes in children, a new analysis has shown. A league table compiled by the charity Diabetes UK from data from the International Diabetes Federation shows that each year 24.5 in every 100 000 children aged up to 14 years are given a diagnosis.… Read More